Table I.

Factor	Split	N	Non- censored N	Median Survival (months)	Log-rank p-value	Hazard Ratio	95% CI	N Allele Sum <36	N Allele Sum ≥36	Fisher p-value
Allele Sum (Surgical Patients)	≥36	29	19	23.1	0.114	1.86	0.86-3.99
Allele Sum (Surgical Patients)	<36	21	14	19.1	0.114	1.86	0.86-3.99
Allele Sum (Combined Patients)	≥36	77	65	10.6	0.313	1.22	0.83-1.78
Allele Sum (Combined Patients)	<36	58	50	9.9	0.313	1.22	0.83-1.78
Min Allele	≥18	35	29	12.2	0.253	1.27	0.84-1.90
Min Allele	<18	100	86	10.1	0.253	1.27	0.84-1.90
Max Allele	≥20	71	61	10.6	0.525	1.13	0.78-1.64
Max Allele	<20	64	54	9.9	0.525	1.13	0.78-1.64
Age	≤65	64	57	13.6	0.390	1.18	0.81-1.70	24	40	0.296
Age	>65	71	58	7.9	0.390	1.18	0.81-1.70	34	37	0.296
Ract	Caucasian	111	93	11.8	*0.003*	2.46	1.35-4.47	49	62	0.818
Ract	African Am	23	22	7.9	*0.003*	2.46	1.35-4.47	9	14	0.818
Sex	Female	71	61	12.2	0.456	1.12	0.78-1.62	35	36	0.163
Sex	Male	64	54	9.1	0.456	1.12	0.78-1.62	23	41	0.163
Stage	I - II	76	61	16.7	*< 0.0001*	3.47	2.230-5.39	33	43	1.000
Stage	III - IV	59	54	7.1	*< 0.0001*	3.47	2.230-5.39	25	34	1.000
Resection with Curative Intent	Yes	50	33	22.3	*< 0.0001*	4.76	3.18-7.14	21	29	1.000
Resection with Curative Intent	No	85	82	7.1	*< 0.0001*	4.76	3.18-7.14	37	48	1.000